NCT01135589View on ClinicalTrials.gov

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

PHASE4UnknownINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
NeutropeniaHematopoietic Stem Cell TransplantationInvasive Fungal Disease
Interventions
DRUG

Micafungin

i.v.

Trial Locations (7)

Unknown

RECRUITING

Busan

RECRUITING

Daegu

RECRUITING

Daejeon

RECRUITING

Goyang

RECRUITING

Hwasun

RECRUITING

Seoul

RECRUITING

Suwon

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Asan Medical Center

OTHER